Clinical Microbiology and Yeast Congress

Yeasts Based Drug Discovery

The humanized yeast model has emerged as a powerful tool in large-scale screenings directed to target human proteins. The high degree of cellular processes conservation between the yeast Saccharomyces cerevisiae and higher eukaryotes has made this microorganism a valuable cell model to study the pathobiology of several human diseases.  The yeast target-based approach can be highly useful in the first-line screening of potential active compounds to be tested in more complex cell models.

Related Conferences

29th Fungal Genetics Conference Asilomar Conference Center, Pacific Grove, California, USA; March 14-19, 2017; Abstract submission opens September 12, 2016 8;Fungal Pathogens Genomics Wellcome Genome Campus, Hinxton, Cambridge, UK,May 11-16, 2017;  7th Advanced Lecture Course on Human Fungal Pathogens (HFP2017) La Colle Sur Loup, France May 13-19, 2017; 13th Yeast Lipid Conference Paris, France May 17-19, 2017

Related Associations

• Society for Industrial Microbiology and Biotechnology (SIMB)
• American Society for Microbiology
• Australian Biotechnology Association
• Biotechnology and Biological Research Council
• Federation of European Microbiological Societies
• Federation of American Societies for Experimental Biology
• North Carolina Association for Biomedical Research
• Society of Bioprocessing Professionals
• The New York Biotechnology Association